BRIEF published on 01/08/2026 at 18:05, 25 days 9 hours ago THX Pharma Releases Shareholder Letter Drug Development Biopharmaceutical Shareholder Communication Neurological Diseases THX Pharma
BRIEF published on 01/08/2026 at 18:05, 25 days 9 hours ago THX Pharma publie une lettre aux actionnaires Biopharmaceutique Communication Aux Actionnaires Développement De Médicaments Maladies Neurologiques THX Pharma
BRIEF published on 01/08/2026 at 18:05, 25 days 9 hours ago Publication of the letter to shareholders by Theranexus Shareholders Neuroscience Rare Diseases Theranexus Drugs
PRESS RELEASE published on 01/08/2026 at 18:00, 25 days 9 hours ago THX Pharma announces the publication of its letter to shareholders THX Pharma (Theranexus) announces the publication of its letter to shareholders, highlighting treatments for rare neurological diseases and upcoming drug commercialization. Forward-looking statements included Forward-looking Statements Theranexus Neurological Diseases THX Pharma Drug Commercialization
PRESS RELEASE published on 01/08/2026 at 18:00, 25 days 9 hours ago THX Pharma annonce la publication de sa lettre aux actionnaires Theranexus annonce la publication de sa lettre aux actionnaires. THX Pharma se spécialise dans le traitement des maladies neurologiques rares. Plus d'infos sur leur site Actionnaires Newsletter Theranexus Maladies Neurologiques Rares THX Pharma
BRIEF published on 01/07/2026 at 08:05, 26 days 19 hours ago THX Pharma Names Julien Veys as Deputy CEO Rare Neurological Diseases THX Pharma Julien Veys Appointment Theranexus Strategy Pharmaceutical Commercialization
BRIEF published on 01/07/2026 at 08:05, 26 days 19 hours ago THX Pharma appoints Julien Veys as Deputy General Manager Business Strategy Appointment THX Pharma Julien Veys Neurological Medications
BRIEF published on 01/07/2026 at 08:05, 26 days 19 hours ago THX Pharma nomme Julien Veys au poste de directeur général adjoint Maladies Neurologiques Rares THX Pharma Nomination De Julien Veys Stratégie Theranexus Commercialisation Pharmaceutique
BRIEF published on 01/07/2026 at 08:05, 26 days 19 hours ago THX Pharma nomme Julien Veys au poste de Directeur général adjoint Nomination Stratégie Commerciale THX Pharma Julien Veys Médicaments Neurologiques
PRESS RELEASE published on 01/07/2026 at 08:00, 26 days 19 hours ago THX Pharma Announces the Appointment of Julien Veys as Deputy Chief Executive Officer THX Pharma appoints Julien Veys as Deputy CEO to drive new strategy focusing on regulatory approval and commercialization of medicines for rare neurological diseases Regulatory Approval Deputy CEO Neurological Diseases THX Pharma Julien Veys
Published on 02/02/2026 at 23:55, 3 hours 48 minutes ago 2026 Tunkillia Development Drilling Programs Begin
Published on 02/02/2026 at 23:55, 3 hours 48 minutes ago 55 North Mining Announces Winter Exploration Drill Program at Last Hope Gold Project
Published on 02/02/2026 at 23:25, 4 hours 18 minutes ago Western Announces Sale of GlassMasters Investment
Published on 02/02/2026 at 22:05, 5 hours 38 minutes ago Organto Foods to Attend Fruit Logistica 2026 in Berlin, Germany From February 4-6, 2026
Published on 02/02/2026 at 15:00, 12 hours 43 minutes ago Jericho Energy Ventures Strategically Terminates SmartKem LOI to Advance Independent Data Center Energy Infrastructure Platform
Published on 02/02/2026 at 20:00, 7 hours 43 minutes ago CGTN AMERICA & CCTV UN: Cultural Event Celebrating the Spring Festival and the 55th Anniversary of China-U.S. Ping-Pong Diplomacy
Published on 02/02/2026 at 19:57, 7 hours 46 minutes ago US federal court grants preliminary injunction allowing Sunrise Wind construction to resume
Published on 02/02/2026 at 19:42, 8 hours ago EQS-Adhoc: ProSiebenSat.1 publishes preliminary figures for financial year 2025
Published on 02/02/2026 at 19:05, 8 hours 38 minutes ago Virtual Science AI launches the life science industry's first medical congress AI solution for real-time event conversational intelligence
Published on 02/02/2026 at 19:00, 8 hours 43 minutes ago PATRIMOINE ET COMMERCE: INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF
Published on 02/02/2026 at 18:23, 9 hours 20 minutes ago Monthly disclosure of the total number of shares and voting rights - January 2026
Published on 02/02/2026 at 18:23, 9 hours 20 minutes ago TF1 - Déclaration mensuelle des actions et droits de vote - Janvier 2026
Published on 02/02/2026 at 18:00, 9 hours 43 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 02/02/2026 at 18:00, 9 hours 43 minutes ago Covivio Hotels - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
Published on 02/02/2026 at 18:00, 9 hours 43 minutes ago Covivio - Informations relatives au nombre total de droits de vote et d’actions composant le capital social
